Affiliation:
1. General surgery department, Faculty of medicine, Ain Shams University
Abstract
Abstract
Background and Aim: For those with a centrally located HCC, the two types of liver sectionectomy that can be performed are extended hepatectomy (EH) and central hepatectomy (CH). The aim of this meta-analysis was to compare the short- and long-term outcomes between patients treated with CH and patients treated with EH for those with centrally located HCC.
Method: We searched PubMed, Scopus, Web of Science, Cochrane library for eligible studies from inception to 1 April 2022 and a systematic review and meta-analysis were done to compare the outcomes between the two groups.
Results: we included 9 studies with total of 1674 patients in this study. The pooled results in this meta-analysis showed equal long-term overall survival, Disease free survival, recurrence and mortality between the two groups (5-year OS, RR = 1.14, 95% CI = 0.96-1.35, P = 0.12; I2 = 56%), (5-year DFS, RR = 0.81, 95% CI = 0.61-1.08, P = 0.15; I2 = 60%), (Recurrence, RR =1.04, 95% CI = 0.94-1.15, P = 0.45; I2 = 27%), and (Mortality, RR =0.55, 95% CI = 0.26-1.15, P = 0.11; I2 = 0 %). In addition to that, no significant difference could be detected in the overall incidence of complications between the two groups (Complications, RR =0.94, 95% CI = 0.76-1.16, P = 0.57; I2 = 0 %).However, CH is associated with a remarkable increase in the rate of biliary fistula (Biliary fistula, RR =1.90, 95% CI = 1.07-3.40, P = 0.03; I2 = 0%). And Liver cell failure was higher in case of EH (LCF, RR =0.47, 95% CI = 0.30-0.76, P = 0.002; I2 = 0%). Regarding the operative details, CH is associated with longer operative time (Time of the operation, Mean difference = 0.82, 95% CI = 0.36, 1.27, P = 0.0004; I2 = 57%).
Conclusion: No significant difference in the short and long-term survival and recurrence between CH and MH for CL-HCC. However, CH is associated with greater future remnant liver volume that decreases the incidence of LCF and provides more opportunities for a repeat hepatectomy after tumor recurrence.
Publisher
Research Square Platform LLC
Reference23 articles.
1. S taging, and M anagement of H epatocellular C arcinoma: 2018 P ractice G uidance by the A merican A ssociation for the S tudy of L iver D iseases;Marrero JA;Hepatology,2018
2. Global epidemiology of hepatocellular carcinoma (HCC epidemiology);Ozakyol A;Journal of gastrointestinal cancer. 2017 Sep
3. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update;Reig M;Journal of Hepatology,2021
4. Yu W, Wang W, Rong W, Wang L, Xu Q, Wu F, Liu L, Wu J. Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin (< 1 cm): a prospective randomized study. Journal of the American College of Surgeons. 2014 Mar 1;218(3):381 – 92.
5. Scudamore CH, Buczkowski AK, Shayan H, Ho SG, Legiehn GM, Chung SW, Owen DA. Mesohepatectomy. The American journal of surgery. 2000 May 15;179(5):356–60.